Skip to main content
Clinical Trials/EUCTR2008-002578-36-FR
EUCTR2008-002578-36-FR
Active, not recruiting
Phase 1

Etude d’efficacité et d’acceptabilité d’un traitement cholinergique dans l’apathie parkinsonienne Cholinergic treatment in Parkinsonian Apathy: ChoPA - I” - ChoPA-I

CHRU de LILLE0 sites29 target enrollmentJuly 21, 2008

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
CHRU de LILLE
Enrollment
29
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 21, 2008
End Date
January 4, 2012
Last Updated
3 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHRU de LILLE

Eligibility Criteria

Inclusion Criteria

  • Parkinson dieases since 5 years
  • MMSE score \=27
  • Matis score \=130
  • No dementia and depression (defined by the DSM\-IV)
  • MADRS score \< 18
  • IF subthalamic stimulation there are more critria
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • more 80 years old
  • dopaminergic treatment
  • Treatment by High frequency stimulation of subthalamic nuclei
  • resting tremor very severe and uncontrolled
  • psychosis dopaminergic
  • Hypersensitivity to cholinesterase ihnibitor
  • Important cardivascular disorder
  • hepatic insufficiency
  • Evolutionary gastro\-duodenal ulcer
  • undernutrited

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Etude de l’efficacité et de la tolérance du traitement par la culture totale lyophilisée de lactobacillus casei variété rhamnosus (Lcr35 Lc) administré par voie vaginale dans la prévention de récidives dans une population de patientes présentant des vaginoses bactériennes récidivantes.Essai de supériorité, randomisé de phase III, en double aveugle versus placebo, multicentrique et international. - Lcr35 Lc (Gynophilus®) dans la prévention de la vaginose bactérienne récidivantevaginose bactérienne récidivanteMedDRA version: 12.1Level: LLTClassification code 10004055Term: Bacterial vaginosis
EUCTR2009-017901-12-FRYOCENTRE140
Active, not recruiting
Not Applicable
ESTUDIO PARA EVALUAR LA EFECTIVIDAD DEL TRATAMIENTO DIETÉTICO CON TRIHEPTANOINA EN PACIENTES CON DEFECTOS DE LA BETA OXIDACIÓN DE LOS ÁCIDOS GRASOS DE CADENA LARGAPACIENTES CON DEFECTOS DE LA BETA OXIDACIÓN DE LOS ÁCIDOS GRASOS DE CADENA LARGA
EUCTR2007-005578-29-ESMª Luz Couce
Completed
Not Applicable
An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes
PER-046-05MERCK & CO.INC., BRISTOL MYERS SQUIBB COMPANY,
Recruiting
Phase 4
Study to determine the effectiveness, acceptability and feasibility of thermotherapy with radio frequency – induced heat therapy (RFHT) by ThermoMed device for the local/intra lesional treatment of cutaneous leishmaniasis in a selected routine clinic settings Sri Lanka.Cutaneous Leishmaniasis
SLCTR/2023/022Faculty of Medicine, University of Colombo200
Active, not recruiting
Not Applicable
Evaluation of educational workshops for health professionals in behaviour changeEducation of health-behaviour changeDiet and Nutrition - Other diet and nutrition disorders
ACTRN12623000525684Curtin University160